Microsoft word - immunization and meningitis certificate 3 2 07.doc
CERTIFICATE OF IMMUNIZATION MANDATORY NEW YORK STATE REQUIREMENTS FOR COLLEGE STUDENTS
Name: ___________________________________________ I.D. or Social Security Number ______________________________
Date of birth: ______________________________________ Semester Entering FLCC: __________________________________ Please note: According to NYS Public Health Law, students enrolling for six (6) or more credit hours (typically two courses) must
submit proof of immunity against measles, mumps and rubella (if born on or after January 1, 1957) and the meningitis response form
below to Student Health Services prior to registering for classes. The student may be withdrawn from classes if this information is not received in the Student Health Services’ office within 30 days of the beginning of the semester. Students admitted to the
A.A.S. Nursing or A.A.S. Therapeutic Massage/Integrated Health Care programs must complete special health forms included in their
acceptance letters and do not submit this form.
MANDATORY IMMUNIZATIONSREQUIREMENTS FOR STUDENTS BORN ON OR AFTER JANUARY 1, 1957: Health Care Provider (Physician/High School Nurse): complete the table below and sign at bottom of page OR attach signed immunization record. 1st Dose 2nd Dose 1. Measles (Rubeola)
given 1968 or after. First dose on or after 12 months of age. The second
dose on or after 15 months of age. 1. Mumps:
received on or after first birthday. 3. Rubella: include certified lab results if vaccine date is unavailable. MENINGITIS RESPONSE FORM (to be completed by all students enrolling for six or more credit hours) Student: Please check one of the following responses below and sign and date: __ I have read, or have had explained to me, the information (on reverse) regarding meningococcal meningitis
disease. I will not obtain immunization against meningococcal meningitis disease.
__ Menomune/Meningococcal meningitis vaccine date: ____________________________
Signed ___________________________________________________________ Date: ________________________________
(Parent or guardian must sign if student is under the age of 18)
The following immunizations are highly recommended but not mandatory. If the student has received any of these, please fill in below: Tetanus-Diptheria - Date of Dose:_________________ PPD (Mantoux) Result: ________________ Date of Reading:____________________ Hepatitis B - Date of first dose: ___________________ Date of second dose: ___________________ Date of third dose: __________________ HEALTH CARE PROVIDER SIGNATURE: x _________________________________________________________________
Phone: (_______)___________________ID Number: _________________________ Date: ______________________________
Return form to: Student Health Services, Finger Lakes Community College, 3325 Marvin Sands Dr., Canandaigua, NY 14424-8395.
Fax: (585)785-1612, Attn: Student Health Services
(Faxes that are not readable or are not complete, cannot be used.)
MENINGOCOCCAL MENINGITIS FACT SHEET WHAT IS MENINGOCOCCAL MENINGITIS? Meningococcal disease is a severe bacterial infection of the bloodstream or meninges (a thin lining covering the brain and spinal cord). It is a relatively rare disease and usually occurs as a single isolated event. Clusters of cases or outbreaks are rare in the United States. HOW IS THE GERM MENINGOCOCCUS SPREAD? Meningococcal disease is transmitted through the air via droplets of respiratory secretions and direct contact with an infected person. Direct contact, for these purposes, is defined as oral contact with shared items such as cigarettes or drinking glasses or through intimate contact such as kissing. Although anyone can come in contact with the bacteria that causes meningococcal disease, data also indicates certain social behaviors, such as exposure to passive and active smoking, bar patronage, and excessive alcohol consumption, may put students at increased risk for the disease. Patients with respiratory infections, compromised immunity, those in close contact to a known case, and travelers to endemic areas of the world are also at increased risk. WHAT ARE THE SYMPTOMS? The early symptoms usually associated with meningococcal disease include fever, severe headache, stiff neck, rash, nausea, vomiting, and lethargy, and may resemble the flu. Because the disease progresses rapidly, often in as little as 12 hours, students are urged to seek medical care immediately if they experience two or more of these symptoms concurrently. The disease is occasionally fatal. HOW SOON DO THE SYMPTOMS APPEAR? The symptoms may appear two to 10 days after exposure, but usually within five days. WHAT IS THE TREATMENT FOR MENINGOCOCCAL DISEASE? Antibiotics, such as penicillin G or ceftriaxone, can be used to treat people with meningococcal disease. SHOULD PEOPLE WHO HAVE BEEN IN CONTACT WITH A DIAGNOSED CASE OF MENINGOCOCCAL MENINGITIS BE TREATED? Only people who have been in close contact (household members, intimate contacts, health care personnel performing mouth-to-mouth resuscitation, day care center playmates, etc.) need to be considered for preventive treatment. Such people are usually advised to obtain a prescription for a special antibiotic (either rifampin, ciprofloxacin or ceftriaxone) from their physician. Casual contact as might occur in a regular classroom, office or factory setting is not usually significant enough to cause concern. IS THERE A VACCINE TO PREVENT MENINGOCOCCAL MENINGITIS? * Presently, there is a vaccine that will protect against some of the strains of meningococcus. It is recommended in outbreak situations, and for those traveling to areas of the world where high rates of the disease are known to occur. For some college students, such as freshman living in dormitories, there is a modestly increased risk of meningococcal disease; students and parents should be educated about meningococcal disease and the availability of a safe and effective vaccine. HOW EFFECTIVE IS THE VACCINE? The meningococcal vaccine has been shown to provide protection against the most common strains of the disease, including serogroups A, C, Y and W-135. The vaccine has shown to be 85 to 100 percent effective in serogroups A and C in older children and adults. IS THE VACCINE SAFE? ARE THERE ADVERSE SIDE EFFECTS TO THE VACCINE? The vaccine is very safe and adverse reactions are mild and infrequent, consisting primarily of redness and pain at the site of injection lasting up to two days. WHAT IS THE DURATION OF PROTECTION? The duration of the menactra vaccine is 10 years. The
menomune vaccine is effective for 3-5 years.
* The vaccination is not available at Finger Lakes Community College. If you are interested in obtaining the vaccine, please call a clinic for an appointment, cost and to determine if the vaccine is available: Clinic and Location Phone
Ontario County Health Dept., 3019 County Complex Dr., Canandaigua, NY 1-800-299-2995 Monroe County Health Dept., 111 Westfall Rd., Rochester, NY (585)274-6000 Wayne County Health Dept., 1519 Nye Rd., Lyons, NY 1-800-724-1170
August 2003. Source: New York State Department of Health Website (Revised March 2003) and the American College Health
Molecular Psychiatry (2001) 6 , 434–439 2001 Nature Publishing Group All rights reserved 1359-4184/01 $15.00 www.nature.com/mp ORIGINAL RESEARCH ARTICLE Role of the serotonin transporter gene in the behavioral expression of autism S Tordjman1,2, L Gutknecht1, M Carlier1, E Spitz1, C Antoine2, F Slama1, V Carsalade2, DJ Cohen3,P Ferrari2, PL Roubertoux1 and GM Anderson31FRE 2134 CNRS